Form D · Biotechnology
Armetheon, Inc.
Menlo Park, CA · CIK 0001617453
Offering snapshot reported Mar 11, 2015 · SEC filing
- Reported sold
- $24.4M Offering amount: $35M
- Investors reported
- 32 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 21, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 11, 2015 | Initial | $24,351,006 | No comparison | 32 | SEC filing |
| Aug 29, 2014 | Initial | $6,999,998 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.38M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-235599
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Locust Walk Securities LLC | 156174 |
Source: Form D, filed Mar 11, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pascal Druzgala | Director, Executive |
| Chung Chiang Hsu | Director |
| Steven P. James | Director |
| Muralitharan Kengatharan | Director, Executive |
| Peter Milner | Director, Executive |
| Kengatharan Muralitharan | Director, Executive |
| Jon Saxe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
325 Sharon Park Drive #303
Menlo Park, CA, 94025
Menlo Park, CA, 94025